CTI BioPharma (FRA:CEPS) Days Payable : 151.17 (As of Mar. 2023)

View and export this data going back to 2007. Start your Free Trial

What is CTI BioPharma Days Payable?

CTI BioPharma's average Accounts Payable for the three months ended in Mar. 2023 was €1.89 Mil. CTI BioPharma's Cost of Goods Sold for the three months ended in Mar. 2023 was €1.14 Mil. Hence, CTI BioPharma's Days Payable for the three months ended in Mar. 2023 was 151.17.

The historical rank and industry rank for CTI BioPharma's Days Payable or its related term are showing as below:

FRA:CEPS' s Days Payable Range Over the Past 10 Years
Min: 196.38 Med: 2326.01 Max: 22800.51
Current: 196.38

During the past 13 years, CTI BioPharma's highest Days Payable was 22800.51. The lowest was 196.38. And the median was 2326.01.

FRA:CEPS's Days Payable is not ranked
in the Biotechnology industry.
Industry Median: 150.695 vs FRA:CEPS: 196.38

CTI BioPharma's Days Payable declined from Mar. 2022 (1,018.18) to Mar. 2023 (151.17). It may suggest that CTI BioPharma accelerated paying its suppliers.

CTI BioPharma Days Payable Historical Data

The historical data trend for CTI BioPharma's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CTI BioPharma Days Payable Chart

CTI BioPharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Payable

Get a 7-Day Free Trial

1,449.85

293.80

CTI BioPharma Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Days Payable	Get a 7-Day Free Trial															1,018.18	270.07	211.73	180.80	151.17

Competitive Comparison of CTI BioPharma's Days Payable

For the Biotechnology subindustry, CTI BioPharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CTI BioPharma's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CTI BioPharma's Days Payable distribution charts can be found below:

* The bar in red indicates where CTI BioPharma's Days Payable falls into.

CTI BioPharma Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

CTI BioPharma's Days Payable for the fiscal year that ended in Dec. 2022 is calculated as

	Days Payable (A: Dec. 2022 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2021 )	+	Accounts Payable (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (3.444	+	1.896)	/	2 )	/	3.317	*	365
=	2.67					/	3.317	*	365
=	293.80

CTI BioPharma's Days Payable for the quarter that ended in Mar. 2023 is calculated as:

	Days Payable (Q: Mar. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2022 )	+	Accounts Payable (Q: Mar. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2023 )	*	Days in Period
=	( (1.896	+	1.891)	/	2 )	/	1.143	*	365 / 4
=	1.8935					/	1.143	*	365 / 4
=	151.17

CTI BioPharma Days Payable Related Terms

Thank you for viewing the detailed overview of CTI BioPharma's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

CTI BioPharma (FRA:CEPS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CTI BioPharma Corp (FRA:CEPS) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

3101 Western Avenue, Suite 800, Seattle, WA, USA, 98121

Website

https://www.ctibiopharma.com

CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under the pipeline include Pacritinib. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

CTI BioPharma (FRA:CEPS) Headlines

No Headlines